Resveratrol Protects Osteoblasts Against Dexamethasone-Induced Cytotoxicity Through Activation of AMP-Activated Protein Kinase

References

• OrayM, Abu SamraK, EbrahimiadibN, MeeseH, FosterCS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15(4):457–465. doi:10.1517/14740338.2016.114074326789102
   PubMed Web of Science ®Google Scholar
• ZhangS, LiuY, LiangQ. Low-dose dexamethasone affects osteoblast viability by inducing autophagy via intracellular ROS. Mol Med Rep. 2018;17:4307–4316.29363725
   PubMed Web of Science ®Google Scholar
• TongX, GuJ, SongR, et al. Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro. J Cell Biochem. 2019;120:1630–1642.
   PubMed Web of Science ®Google Scholar
• KimJY, MinJY, BaekJM, et al. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo. Bone. 2015;79:242–251.26103094
   PubMed Web of Science ®Google Scholar
• WangYG, QuXH, YangY, et al. AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis. Cell Signal. 2016;28:1270–1282.27283242
   PubMed Web of Science ®Google Scholar
• BandowK, KusuyamaJ, KakimotoK, OhnishiT, MatsuguchiT. AMP-activated protein kinase (AMPK) activity negatively regulates chondrogenic differentiation. Bone. 2015;74:125–133.25497570
   PubMed Web of Science ®Google Scholar
• StegenS, van GastelN, EelenG, et al. HIF-1α promotes glutamine-mediated redox homeostasis and glycogen-dependent bioenergetics to support postimplantation bone cell survival. Cell Metab. 2016;23:265–279.26863487
   PubMed Web of Science ®Google Scholar
• MatsudaY, MinagawaT, OkuiT, YamazakiK. Resveratrol suppresses the alveolar bone resorption induced by artificial trauma from occlusion in mice. Oral Dis. 2018;24(3):412–421.28944599
   PubMed Web of Science ®Google Scholar
• BoS, GambinoR, PonzoV, et al. Effects of resveratrol on bone health in type 2 diabetic patients. A double-blind randomized-controlled trial. Nutr Diabetes. 2018;8(1):51.30237505
   PubMed Web of Science ®Google Scholar
• JiangY, LuoW, WangB, WangX, GongP, XiongY. Resveratrol promotes osteogenesis via activating SIRT1/FoxO1 pathway in osteoporosis mice. Life Sci. 2020;246:117422. doi:10.1016/j.lfs.2020.11742232057903
   PubMed Web of Science ®Google Scholar
• YangX, JiangT, WangY, GuoL. The Role and Mechanism of SIRT1 in Resveratrol-regulated Osteoblast Autophagy in Osteoporosis Rats. Sci Rep. 2019;9(1):18424. doi:10.1038/s41598-019-44766-331804494
   PubMed Web of Science ®Google Scholar
• HuangY, HuoJ, LiuFQ, et al. Resveratrol Promotes in vitro Differentiation of Osteoblastic MC3T3-E1 Cells via Potentiation of the Calcineurin/NFATc1 Signaling Pathway. Biochemistry (Mosc). 2019;84(6):686–692. doi:10.1134/S000629791906011731238868
   PubMed Web of Science ®Google Scholar
• GaoJ, FengZ, WangX, et al. SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ. 2018;25(2):229–240. doi:10.1038/cdd.2017.14428914882
   PubMed Web of Science ®Google Scholar
• WangN, WangF, GaoY, et al. Curcumin protects human adipose-derived mesenchymal stem cells against oxidative stress-induced inhibition of osteogenesis. J Pharmacol Sci. 2016;132(3):192–200. doi:10.1016/j.jphs.2016.10.00527840063
   PubMed Web of Science ®Google Scholar
• YangM, HuangY, ChenJ, ChenY-L, Ma-J-J, ShiP-H. Activation of AMPK participates hydrogen sulfide-induced cyto-protective effect against dexamethasone in osteoblastic MC3T3-E1 cells. Biochemical and Biophysical Research Communications. 2014;454(1):42–47. doi:10.1016/j.bbrc.2014.10.03325445596
   PubMed Web of Science ®Google Scholar
• ShahM, KolaB, BataveljicA, et al. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone. 2010;47(2):309–319. doi:10.1016/j.bone.2010.04.59620399918
   PubMed Web of Science ®Google Scholar
• TsurufujiS, SugioK, TakemasaF. The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature. 1979;280(5721):408–410. doi:10.1038/280408a0460415
   PubMed Web of Science ®Google Scholar
• LiuC, YangN, ChenX, et al. The Flavonoid 7, 4′‐Dihydroxyflavone Prevents Dexamethasone Paradoxical Adverse Effect on Eotaxin Production by Human Fibroblasts. Phytother Res. 2017;31:449–458.28102022
   PubMed Web of Science ®Google Scholar
• GilesAJ, HutchinsonM-KND, SonnemannHM, et al. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer. 2018;6(1):51. doi:10.1186/s40425-018-0371-529891009
   PubMed Web of Science ®Google Scholar
• KunickaJE, TalleMA, DenhardtGH, BrownM, PrinceLA, GoldsteinG. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cellular Immunology. 1993;149(1):39–49. doi:10.1006/cimm.1993.11348513511
   PubMed Web of Science ®Google Scholar
• De GansJ, van de BeekD. Van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347(20):1549–1556. doi:10.1056/NEJMoa02133412432041
   PubMed Web of Science ®Google Scholar
• StewartAK, RajkumarSV, DimopoulosMA, et al. Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma. N Engl J Med. 2015;372(2):142–152. doi:10.1056/NEJMoa141132125482145
   PubMed Web of Science ®Google Scholar
• HeimdalK, HirschbergH, SlettebøH, WatneK, NomeO. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol. 1992;12(2):141–144. doi:10.1007/BF001726641560260
   PubMed Web of Science ®Google Scholar
• BordagN, KlieS, JürchottK, et al. Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects. Sci Rep. 2015;5(1):15954. doi:10.1038/srep1595426526738
   PubMed Web of Science ®Google Scholar
• ChengSL, YangJW, RifasL, ZhangSF, AvioliLV. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone.. Endocrinology. 1994;134(1):277–286. doi:10.1210/endo.134.1.82759458275945
   PubMed Web of Science ®Google Scholar
• BhattaraiG, PoudelSB, KookS-H, LeeJ-C. Resveratrol prevents alveolar bone loss in an experimental rat model of periodontitis. Acta Biomater. 2016;29:398–408. doi:10.1016/j.actbio.2015.10.03126497626
   PubMed Web of Science ®Google Scholar
• WalshS, JordanGR, JefferissC, StewartK, BeresfordJN. High concentrations of dexamethasone suppress the proliferation but not the differentiation or further maturation of human osteoblast precursors in vitro: relevance to glucocorticoid‐induced osteoporosis. Rheumatology. 2001;40:74–83.11157145
   PubMed Web of Science ®Google Scholar
• Inkielewicz-StepniakI, RadomskiMW, WozniakM. Fisetin prevents fluoride-and dexamethasone-induced oxidative damage in osteoblast and hippocampal cells. Food Chem Toxicol. 2012;50:583–589.22198064
   PubMed Web of Science ®Google Scholar
• WangL, HeckmannBL, YangX, LongH. Osteoblast autophagy in glucocorticoid‐induced osteoporosis. J Cell Physiol. 2019;234:3207–3215.30417506
   PubMed Web of Science ®Google Scholar
• ZhaoY, WangH, LiT, YangF, TzengC. Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway. Drug Des Devel Ther. 2020;14:195–206.
   PubMed Web of Science ®Google Scholar
• XuYY, ChenFL, JiF, FeiHD, XieY, WangSG. Activation of AMP-activated protein kinase by compound 991 protects osteoblasts from dexamethasone. Biochem Biophys Res Commun. 2018;495:1014–1021.29175330
   PubMed Web of Science ®Google Scholar
• LiuS, FangT, YangL, ChenZ, MuS, FuQ. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway. Int J Mol Med. 2018;41:2059–2069.29393365
   PubMed Web of Science ®Google Scholar
• MurgiaD, MauceriR, CampisiG, De CaroV. Advance on Resveratrol Application in Bone Regeneration: progress and Perspectives for Use in Oral and Maxillofacial Surgery. Biomolecules. 2019;9:94.
   PubMed Web of Science ®Google Scholar
• TouJC. Resveratrol supplementation affects bone acquisition and osteoporosis: pre-clinical evidence toward translational diet therapy. Biochim Biophys Acta. 2015;1852:1186–1194.25315301
   PubMed Web of Science ®Google Scholar
• QinN, WeiL, LiW, et al. Local intra-articular injection of resveratrol delays cartilage degeneration in C57BL/6 mice by inducing autophagy via AMPK/mTOR pathway. J Pharmacol Sci. 2017;134:166–174.28669597
   PubMed Web of Science ®Google Scholar
• LeeWC, GunturAR, LongF, RosenCJ. Energy Metabolism of the Osteoblast: implications for Osteoporosis. Endocr Rev. 2017;38(3):255–266.28472361
   PubMed Web of Science ®Google Scholar
• JinZ, WeiW, YangM, DuY, WanY. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metab. 2014;20:483–498.25130399
   PubMed Web of Science ®Google Scholar
• MaJ, FuQ, WangZ, et al. Sodium hydrosulfide mitigates dexamethasone‐induced osteoblast dysfunction by interfering with mitochondrial function. Biotechnol Appl Biochem. 2019;66:690–697.31173404
   PubMed Web of Science ®Google Scholar
• IshiiKA, FumotoT, IwaiK, et al. Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med. 2009;15:259–266.19252502
   PubMed Web of Science ®Google Scholar
• LiangJ, ZhangXY, ZhenYF, et al. PGK1 depletion activates Nrf2 signaling to protect human osteoblasts from dexamethasone. Cell Death Dis. 2019;10:888.31767834
   PubMed Web of Science ®Google Scholar
• CaoX, LuoD, LiT, et al. MnTBAP inhibits bone loss in ovariectomized rats by reducing mitochondrial oxidative stress in osteoblasts. J Bone Miner Metab. 2020;38:27–37.31493249
   PubMed Web of Science ®Google Scholar
• LobodaA, DamulewiczM, PyzaE, JozkowiczA, DulakJ. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73:3221–3247.27100828
   PubMed Web of Science ®Google Scholar
• KovacS, AngelovaPR, HolmströmKM, ZhangY, Dinkova-KostovaAT, AbramovAY. Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochim Biophys Acta. 2015;1850:794–801.25484314
   PubMed Web of Science ®Google Scholar
• HanD, GuX, GaoJ, et al. Chlorogenic acid promotes the Nrf2/HO-1 anti-oxidative pathway by activating p21Waf1/Cip1 to resist dexamethasone-induced apoptosis in osteoblastic cells. Free Radic Biol Med. 2019;137:1–12.31004750
   PubMed Web of Science ®Google Scholar
• St-PierreJ, LinJ, KraussS, et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem. 2003;278(29):26597–26603.12734177
   PubMed Web of Science ®Google Scholar
• KongX, WangR, XueY, et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One. 2010;5(7):e11707.20661474
   PubMed Web of Science ®Google Scholar
• WangEA, RosenV, D’AlessandroJS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Nati Acad Sci. 1990;87:2220–2224.
   PubMed Web of Science ®Google Scholar
• KomoriT. Regulation of bone development and maintenance by Runx2. Front Biosci. 2008;13:898–903.17981598
   PubMed Web of Science ®Google Scholar
• BoyceBF, XingL. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 2008;473:139–146.18395508
   PubMed Web of Science ®Google Scholar